Auf dieser Seite
SLDB Solid Biosciences Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$6,85
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$3,7952-Wochen-Tief
$11,4552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$720M
P/E
-3.4
EPS
$-1.99
Ihre Abzeichen
52W-Spanne
$4–$11
Analystenbewertung
BUY
Kursziel
$19
P/E
-3.4
ROE
-79.5%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
SLDB Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$6.85
Marktkapitalisierung (MRQ)
$720M
P/E
-3.4
EPS
$-1.99
ROE
-79.5%
52W-Spanne
$4–$11
SLDB Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 28. Oktober 2022 | 1-for-15 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz·2016-12-31 → 2022-12-31
EPS$-1.992020-12-31 → 2025-12-31
Freier Cashflow$-157M2018-12-31 → 2025-12-31
Nettogewinnmarge·2021-12-31 → 2022-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | SLDB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -3.45-Jahres-Durchschnitt ≈-1.7 | ≈-1.7 | · | · | |
| K/B (MRQ) | 1.95-Jahres-Durchschnitt ≈3.8 | ≈3.8 | 3.2 | Fairer Wert | |
| Kurs / FCF (TTM) | -3.85-Jahres-Durchschnitt ≈-8.7 | ≈-8.7 | · | · | |
| Kurs / Cashflow (TTM) | -3.95-Jahres-Durchschnitt ≈-8.8 | ≈-8.8 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 3.05-Jahres-Durchschnitt ≈3.8 | ≈3.8 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | SLDB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -82.8%5-Jahres-Durchschnitt ≈-53.8% | ≈-53.8% | -46.1% | Schwach | |
| ROE | -79.5%5-Jahres-Durchschnitt ≈-62.9% | ≈-62.9% | -53.7% | Schwach | |
| ROIC | -99.6% | · | -34.2% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | SLDB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 13.85-Jahres-Durchschnitt ≈7.9 | ≈7.9 | 14.4 | Im Einklang | |
| Quick Ratio | 1.85-Jahres-Durchschnitt ≈4.3 | ≈4.3 | 6.6 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-1.7%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.38 | $-0.48 | 20.4% |
| 31. März 2026 | Mai 13, 2026 | $-0.52 | $-0.44 | -17.6% |
| 31. Dezember 2025 | $-0.53 | $-0.53 | -0.15% | |
| 30. September 2025 | $-0.48 | $-0.45 | -7.3% | |
| 30. Juni 2025 | $-0.42 | $-0.51 | 18.3% | |
| 31. März 2025 | $-0.59 | $-0.57 | -4.1% | |
| 31. Dezember 2024 | $-1.00 | $-0.82 | -21.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $8M | $14M | $0 | $0 | $0 | $0 | |
| R&D Expense | $140M | $96M | $77M | $78M | $59M | $65M | $95M | $58M | $40M | |
| SG&A Expense | $39M | $33M | $28M | $29M | $27M | $22M | $25M | $18M | $15M | |
| Operating Expenses | $179M | $130M | $104M | $115M | $86M | $88M | $119M | $76M | $55M | |
| Operating Income | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | $-119M | $-76M | $-55M | |
| Interest Income | $10M | $9M | $8M | $3M | $64.0K | $115.0K | $2M | $619.0K | $219.0K | |
| Other Non-op | $824.0K | $652.0K | $1M | $-381.0K | $2.0K | $1.0K | $515.0K | $270.0K | $1M | |
| Pretax Income | $-174M | $-125M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| EPS (Basic) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| EPS (Diluted) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| Shares (Basic) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| Shares (Diluted) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| EBITDA | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | · | $-76M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $80M | $74M | $155M | $119M | $155M | $76M | $86M | $52M | |
| Short-term Investments | · | · | · | · | · | · | · | $36M | $17M | |
| Prepaid Expense | $16M | $8M | $6M | $6M | $15M | $4M | $3M | $6M | $1M | |
| Current Assets | $205M | $157M | $130M | $220M | $223M | $159M | $86M | $129M | $71M | |
| PP&E (Net) | $4M | $5M | $7M | $10M | $6M | $8M | $12M | $10M | $2M | |
| PP&E (Gross) | $18M | $18M | $19M | $21M | $18M | $17M | $16M | $12M | $3M | |
| Accum. Depreciation | $14M | $13M | $13M | $11M | $12M | $9M | $5M | $2M | $504.0K | |
| Other Non-current Assets | $223.0K | $366.0K | $209.0K | $175.0K | $94.0K | $209.0K | $209.0K | $209.0K | · | |
| Total Assets | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Accounts Payable | $3M | $4M | $2M | $3M | $4M | $3M | $7M | $4M | $5M | |
| Accrued Liabilities | $19M | $20M | $10M | $17M | $10M | $9M | $9M | $8M | $6M | |
| Current Liabilities | $33M | $30M | $15M | $23M | $24M | $24M | $18M | $12M | $11M | |
| Capital Leases | $19M | $21M | $23M | $24M | $275.0K | $2M | $4M | $859.0K | · | |
| Other Non-current Liabilities | · | · | · | $96.0K | · | $1M | · | $1M | · | |
| Total Liabilities | $53M | $51M | $38M | $49M | $24M | $39M | $23M | $14M | $11M | |
| Common Stock | $79.0K | $40.0K | $20.0K | $20.0K | $7.0K | $87.0K | $48.0K | $35.0K | · | |
| Retained Earnings | $-958M | $-783M | $-659M | $-563M | $-477M | $-405M | $-316M | $-199M | $-124M | |
| AOCI | $52.0K | $47.0K | $15.0K | $-68.0K | $-45.0K | $0 | $1.0K | $-5.0K | $-13.0K | |
| Stockholders' Equity | $180M | $137M | $126M | $212M | $208M | $132M | $80M | $125M | $-59M | |
| Liabilities + Equity | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Shares Outstanding | 78,967,888 | 40,468,141 | 20,386,606 | 19,556,732 | 7,356,017 | 84,893,994 | 45,987,571 | 35,432,460 | 0 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $2M | $3M | $4M | $3M | · | · | |
| Stock-based Comp | $17M | $11M | $8M | $8M | $13M | $12M | $14M | $6M | $5M | |
| Restructuring | · | · | $-63.0K | $7M | · | $2M | · | · | · | |
| Operating Cash Flow | $-156M | $-100M | $-94M | $-98M | $-78M | $-57M | $-93M | $-70M | $-43M | |
| CapEx | $1M | $654.0K | $2M | $3M | $1M | $899.0K | $4M | $8M | $2M | |
| Investing Cash Flow | $-58M | $-16M | $10M | $59M | $-91M | $7M | $25M | $-27M | $10M | |
| Stock Issued | · | · | $3M | $73M | $135M | $113M | $49M | · | · | |
| Net Stock Activity | · | · | $3M | $73M | $135M | $113M | · | · | · | |
| Financing Cash Flow | $194M | $122M | $3M | $75M | $135M | $129M | $58M | $132M | $77M | |
| Net Change in Cash | $-20M | $6M | $-81M | $36M | $-34M | $79M | $-10M | $35M | $44M | |
| Free Cash Flow | $-157M | $-101M | $-96M | $-101M | $-79M | $-57M | · | $-78M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| Net Margin | · | · | · | -1062.3% | -530.0% | · | · | · | · | |
| EBITDA Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| ROA | -82.8% | -70.5% | -45.2% | -34.9% | -35.8% | -64.3% | · | -69.3% | · | |
| ROE | -79.5% | -82.0% | -70.9% | -48.4% | -33.5% | -114.4% | · | -55.4% | · | |
| ROIC | -99.6% | · | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 | 6.5 | · | 10.3 | · | |
| Quick Ratio | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 | 6.3 | · | 6.9 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.0 | · | 0.0 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.28 | $3.39 | $6.20 | $10.82 | $1.89 | $1.56 | · | $3.53 | · | |
| Revenue / Share | · | · | · | $0.95 | · | · | · | · | · | |
| Cash Flow / Share | $-1.79 | $-2.45 | $-4.74 | $-11.51 | · | · | · | · | · | |
| Cash / Share | $0.76 | $1.98 | $3.63 | $7.95 | $1.08 | $1.82 | · | $2.44 | · | |
| EPS (TTM) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -40.6% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $8M | $14M | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| Market Cap | $445M | $162M | $125M | $105M | $2.90B | $9.65B | · | $14.24B | · | |
| P/E | -2.8 | -1.3 | -1.3 | -0.5 | -2.6 | -4.5 | · | · | · | |
| P/S | · | · | · | 13.0 | 212.7 | · | · | · | · | |
| P/B | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | 113.8 | · | |
| P / Tangible Book | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | · | · | |
| P / Cash Flow | -2.8 | -1.6 | -1.3 | -1.1 | -37.2 | -170.5 | · | -202.9 | · | |
| P / FCF | -2.8 | -1.6 | -1.3 | -1.0 | -36.6 | -167.9 | · | -182.7 | · | |
| Earnings Yield | -35.3% | -76.5% | -78.7% | -187.7% | -38.6% | -22.4% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $44M | $46M | $38M | $39M | $32M | $31M | $31M | $27M | $19M | $19M | $15M | $17M | $20M | $25M | $21M | $14M | |
| SG&A Expense | $13M | $11M | $11M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $6M | $7M | $7M | $8M | $7M | |
| Operating Expenses | $57M | $57M | $49M | $48M | $42M | $40M | $40M | $35M | $28M | $27M | $22M | $23M | $27M | $32M | $35M | $21M | |
| Operating Income | $-57M | $-57M | $-49M | $-48M | $-42M | $-40M | $-40M | $-35M | $-28M | $-27M | $-22M | $-23M | $-27M | $-32M | $-35M | $-21M | |
| Interest Expense | · | · | · | · | · | · | · | · | $88.0K | $95.0K | · | · | $111.0K | $121.0K | · | · | |
| Interest Income | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $735.0K | |
| Other Non-op | $214.0K | $157.0K | $219.0K | $210.0K | $207.0K | $188.0K | $199.0K | $211.0K | $239.0K | $3.0K | $270.0K | $278.0K | $265.0K | $282.0K | $-355.0K | $-13.0K | |
| Income Tax | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-55M | $-57M | $-50M | $-46M | $-39M | $-39M | $-43M | $-33M | $-25M | $-24M | $-20M | $-21M | $-25M | $-30M | $-15M | $-20M | |
| EPS (Basic) | $-0.38 | $-0.52 | $-0.50 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | |
| EPS (Diluted) | $-0.38 | $-0.52 | $-0.67 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | |
| Shares (Basic) | 143,688,701 | 109,811,461 | · | 94,417,746 | 94,140,286 | 66,341,305 | · | 41,443,317 | 40,934,361 | 38,155,373 | · | 20,059,641 | 19,663,672 | 19,567,635 | · | 7,532,706 | |
| Shares (Diluted) | 143,688,701 | 109,811,461 | · | 94,417,746 | 94,140,286 | 66,341,305 | · | 41,443,317 | 40,934,361 | 38,155,373 | · | 20,059,641 | 19,663,672 | 19,567,635 | · | 7,532,706 | |
| EBITDA | $-57M | $-57M | · | $-48M | $-42M | $-40M | · | $-35M | $-28M | $-27M | · | $-23M | $-27M | $-32M | · | $-21M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159M | $297M | $60M | $61M | $139M | $211M | $80M | $64M | $96M | $118M | $74M | $49M | $92M | $165M | $155M | $49M | |
| Prepaid Expense | $17M | $15M | $16M | $9M | $11M | $6M | $8M | $8M | $7M | $8M | $6M | $5M | $7M | $5M | $6M | $5M | |
| Current Assets | $395M | $397M | $205M | $245M | $279M | $313M | $157M | $179M | $198M | $214M | $130M | $148M | $167M | $191M | $220M | $148M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $7M | $7M | $9M | $10M | $6M | |
| PP&E (Gross) | · | · | $18M | · | · | · | $18M | · | · | $19M | $19M | $19M | $19M | $19M | $21M | $16M | |
| Accum. Depreciation | · | · | $14M | · | · | · | $13M | · | · | $13M | $13M | $12M | $12M | $11M | $11M | $9M | |
| Other Non-current Assets | $138.0K | $183.0K | $223.0K | $247.0K | $278.0K | $319.0K | $366.0K | $475.0K | $515.0K | $175.0K | $209.0K | $315.0K | $181.0K | $238.0K | $175.0K | $422.0K | |
| Total Assets | $421M | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | |
| Accounts Payable | $4M | $6M | $3M | $8M | $5M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $3M | $6M | $3M | $5M | |
| Accrued Liabilities | $18M | $19M | $19M | $19M | $17M | $15M | $20M | $13M | $10M | $10M | $10M | $11M | $11M | $12M | $17M | $10M | |
| Current Liabilities | $29M | $30M | $33M | $36M | $30M | $29M | $30M | $23M | $15M | $14M | $15M | $16M | $16M | $20M | $23M | $17M | |
| Capital Leases | $18M | $18M | $19M | $20M | $20M | $21M | $21M | $22M | $22M | $23M | $23M | $23M | $24M | $24M | $24M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $96.0K | · | |
| Total Liabilities | $47M | $49M | $53M | $56M | $50M | $49M | $51M | $45M | $38M | $38M | $38M | $40M | $41M | $46M | $49M | $41M | |
| Common Stock | $105.0K | $98.0K | $79.0K | $78.0K | $78.0K | $77.0K | $40.0K | $39.0K | $39.0K | $38.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $8.0K | |
| Retained Earnings | $-1.07B | $-1.01B | $-958M | $-908M | $-862M | $-823M | $-783M | $-741M | $-708M | $-683M | $-659M | $-638M | $-617M | $-593M | $-563M | $-548M | |
| AOCI | $-113.0K | $-13.0K | $52.0K | $48.0K | $-38.0K | $2.0K | $47.0K | $116.0K | $-15.0K | $-4.0K | $15.0K | $2.0K | $14.0K | $5.0K | $-68.0K | $-196.0K | |
| Stockholders' Equity | $374M | $374M | $180M | $218M | $258M | $294M | $137M | $167M | $193M | $211M | $126M | $144M | $164M | $184M | $212M | $143M | |
| Liabilities + Equity | $421M | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | |
| Shares Outstanding | 105,125,366 | 98,394,720 | 78,967,888 | 77,882,685 | 77,602,741 | 77,492,959 | 40,468,141 | 38,930,203 | 38,551,059 | 37,833,689 | 20,386,606 | 20,061,751 | 20,044,389 | 19,573,132 | 19,556,732 | 7,533,081 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $391.0K | $395.0K | $467.0K | $376.0K | $386.0K | $407.0K | $488.0K | $405.0K | $1M | $327.0K | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $5M | $6M | $4M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $-63.0K | · | $6M | $0 | |
| Operating Cash Flow | $-53M | $-47M | $-54M | $-33M | $-37M | $-32M | $-30M | $-24M | $-21M | $-25M | $-21M | $-18M | $-27M | $-28M | $-34M | $-20M | |
| CapEx | $150.0K | $165.0K | $565.0K | $85.0K | $377.0K | $126.0K | $204.0K | $15.0K | $286.0K | $149.0K | $90.0K | $383.0K | $536.0K | $506.0K | $856.0K | $839.0K | |
| Investing Cash Flow | $-134M | $45M | $47M | $-45M | $-33M | $-27M | $39M | $-11M | $-5M | $-38M | $45M | $-25M | $-48M | $37M | $66M | $15M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $48M | $239M | $5M | $1M | $-2M | $190M | $7M | $3M | $5M | $107M | $505.0K | $0 | · | · | $75M | $-1.0K | |
| Net Change in Cash | $-138M | $237M | $-1M | $-78M | $-72M | $130M | $16M | $-31M | $-22M | $44M | $25M | $-43M | $-73M | $9M | $106M | $-6M | |
| Free Cash Flow | · | $-47M | · | · | · | $-32M | · | · | · | $-25M | · | · | · | $-29M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.0% | -14.8% | · | -18.9% | -14.6% | -13.3% | · | -16.5% | -11.5% | -10.2% | · | -11.4% | -11.9% | -13.8% | · | -9.4% | |
| ROE | -17.3% | -17.0% | · | -23.8% | -17.5% | -15.6% | · | -21.0% | -14.1% | -12.3% | · | -14.6% | -15.1% | -16.3% | · | -11.1% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.8 | 13.1 | · | 6.7 | 9.3 | 10.9 | · | 7.9 | 13.5 | 14.9 | · | 9.4 | 10.6 | 9.4 | · | 8.7 | |
| Quick Ratio | 5.6 | 9.8 | · | 1.7 | 4.7 | 7.3 | · | 2.8 | 6.5 | 8.2 | · | 3.1 | 5.8 | 8.1 | · | 2.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -315.8 | -282.8 | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.56 | $3.80 | · | $2.80 | $3.33 | $3.80 | · | $4.29 | $5.01 | $5.57 | · | $7.20 | $8.17 | $9.39 | · | $19.02 | |
| Cash Flow / Share | · | $-0.43 | · | · | · | $-0.48 | · | · | · | $-0.66 | · | · | · | $-1.43 | · | · | |
| Cash / Share | $1.52 | $3.02 | · | $0.79 | $1.79 | $2.72 | · | $1.65 | $2.49 | $3.11 | · | $2.44 | $4.57 | $8.41 | · | $6.48 | |
| EPS (TTM) | $-2.05 | $-2.09 | · | $-2.51 | $-2.82 | $-3.01 | · | $-3.03 | $-3.29 | $-3.93 | · | $-4.53 | $-6.19 | $-8.27 | · | $-11.87 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-207M | $-192M | · | $-167M | $-154M | $-140M | · | $-102M | $-91M | $-90M | · | $-91M | $-90M | $-91M | · | $-89M | |
| Market Cap | $1.05B | $708M | · | $481M | $378M | $287M | · | $271M | $219M | $504M | · | $51M | $105M | $93M | · | $53M | |
| P/E | -4.9 | -3.4 | · | -2.5 | -1.7 | -1.2 | · | -2.3 | -1.7 | -3.4 | · | -0.6 | -0.8 | -0.6 | · | -0.6 | |
| P/B | 2.8 | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | |
| P / Tangible Book | 2.8 | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | |
| P / Cash Flow | · | -15.0 | · | · | · | -9.0 | · | · | · | -20.0 | · | · | · | -3.3 | · | · | |
| Earnings Yield | -20.5% | -29.0% | · | -40.7% | -57.9% | -81.3% | · | -43.5% | -58.0% | -29.5% | · | -179.8% | -118.1% | -174.5% | · | -169.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | · | · | · | $8M | $14M |
| Betriebsgewinnmarge % | · | · | · | -1315.2% | -530.5% |
| Nettoergebnis | $-174M | $-125M | $-96M | $-86M | $-72M |
| Verwässerte EPS | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 |
| Quick Ratio | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-157M | $-101M | $-96M | $-101M | $-79M |
Institutionelle Eigentümer (13F) 165 Einreicher · $1.2B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
165
Gehaltener Wert
$1.2B
Neue Positionen
42
Geschlossene Positionen
25
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 42 (+4 vs. Vorquartal) | 25 (+13 vs. Vorquartal) | 58 (+2 vs. Vorquartal) | 38 (-2 vs. Vorquartal) | +13.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $120.240.899 | 12.036.126 | 10,43% | Aktien |
| PERCEPTIVE ADVISORS LLC | $118.947.393 | 11.906.646 | 10,31% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $97.990.102 | 9.808.819 | 8,50% | Aktien |
| Siren, L.L.C. | $76.827.146 | 7.690.405 | 6,66% | Aktien |
| BlackRock, Inc. | $69.273.136 | 6.934.248 | 6,01% | Aktien |
| FMR LLC | $68.690.808 | 6.875.957 | 5,96% | Aktien |
| ARMISTICE CAPITAL, LLC | $42.737.220 | 4.278.000 | 3,71% | Aktien |
| STATE STREET CORP | $41.711.896 | 4.175.365 | 3,62% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.059.121 | 4.009.922 | 3,47% | Aktien |
| RTW INVESTMENTS, LP | $38.890.331 | 3.892.926 | 3,37% | Aktien |
| Deep Track Capital, LP | $35.614.969 | 3.565.062 | 3,09% | Aktien |
| FRANKLIN RESOURCES INC | $34.372.673 | 3.440.708 | 2,98% | Aktien |
| JANUS HENDERSON GROUP PLC | $28.877.004 | 4.010.695 | 2,50% | Aktien |
| CITADEL ADVISORS LLC | $28.123.069 | 2.815.122 | 2,44% | Aktien |
| Alyeska Investment Group, L.P. | $22.782.035 | 2.280.484 | 1,98% | Aktien |
| AMERIPRISE FINANCIAL INC | $22.235.593 | 2.225.783 | 1,93% | Aktien |
| Vestal Point Capital, LP | $21.578.400 | 2.160.000 | 1,87% | Aktien |
| VANGUARD GROUP INC | $19.485.969 | 3.454.959 | 1,69% | Aktien |
| Redmile Group, LLC | $19.467.463 | 1.948.695 | 1,69% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $19.391.710 | 1.940.824 | 1,68% | Aktien |
| GOLDMAN SACHS GROUP INC | $16.013.141 | 1.602.917 | 1,39% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $15.049.995 | 1.506.506 | 1,30% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $12.645.298 | 1.266.290 | 1,10% | Aktien |
| BLAIR WILLIAM & CO/IL | $7.555.207 | 756.277 | 0,66% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.478.404 | 748.589 | 0,65% | Aktien |
| Woodline Partners LP | $6.734.019 | 674.076 | 0,58% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $6.677.816 | 668.450 | 0,58% | Aktien |
| Birchview Capital, LP | $6.655.298 | 666.196 | 0,58% | Aktien |
| NORTHERN TRUST CORP | $6.030.434 | 603.647 | 0,52% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $6.028.685 | 603.472 | 0,52% | Aktien |
| BANK OF AMERICA CORP /DE/ | $5.235.779 | 524.102 | 0,45% | Aktien |
| Monashee Investment Management LLC | $4.995.000 | 500.000 | 0,43% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.942.353 | 494.730 | 0,43% | Aktien |
| Point72 Asset Management, L.P. | $4.475.600 | 448.008 | 0,39% | Aktien |
| STEMPOINT CAPITAL LP | $3.584.212 | 358.780 | 0,31% | Aktien |
| Boxer Capital Management, LLC | $2.997.000 | 300.000 | 0,26% | Aktien |
| JPMORGAN CHASE & CO | $2.667.443 | 281.673 | 0,23% | Aktien |
| Ally Bridge Group (NY) LLC | $2.557.030 | 255.959 | 0,22% | Aktien |
| MORGAN STANLEY | $2.549.403 | 255.195 | 0,22% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.441.566 | 244.401 | 0,21% | Aktien |
| Bank of New York Mellon Corp | $2.429.105 | 243.154 | 0,21% | Aktien |
| J. Goldman & Co LP | $2.419.218 | 242.164 | 0,21% | Aktien |
| Nuveen, LLC | $2.414.004 | 241.642 | 0,21% | Aktien |
| D. E. Shaw & Co., Inc. | $2.225.662 | 222.789 | 0,19% | Aktien |
| UBS Group AG | $1.881.587 | 188.347 | 0,16% | Aktien |
| ALGERT GLOBAL LLC | $1.872.316 | 187.419 | 0,16% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.851.797 | 185.365 | 0,16% | Aktien |
| Balyasny Asset Management L.P. | $1.780.747 | 178.253 | 0,15% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.628.740 | 163.037 | 0,14% | Aktien |
| Apis Capital Advisors, LLC | $1.598.400 | 160.000 | 0,14% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., Perceptive Xontogeny Venture Fund, LP ×11 Einreichungen | 14. August 2026 | 11,20% | Änderung | · | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×12 Einreichungen | 24. Juni 2026 | 11,90% | Änderung | · | SEC |
| BCLS SB Investco, LP, Bain Capital Life Sciences Fund II, L.P., BCLS II Investco, LP, BCIP Life Sciences Associates, LP, BCLS II Equity Opportunities, LP, Bain Capital Life Sciences Opportunities IV, L.P. ×12 Einreichungen | 10. März 2026 | 8,80% | Änderung | · | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×2 Einreichungen | 30. Juli 2019 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 29 Insider · 13 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Alexander Cumbo | President and CEO | 29. Januar 2026 A | 235.405 | 0 | 4 | $-983.959 |
| Kevin Tan | CFO & Treasurer | 29. Januar 2026 A | 99.422 | 0 | 4 | $-329.544 |
| Jennifer Lynn Ziolkowski | CFO, Treasurer & Asst. Secy | 27. Januar 2021 M | 335.636 | 0 | 0 | $0 |
| David T Howton | Chief Operating Officer | 29. Januar 2026 A | 105.077 | 0 | 4 | $-433.595 |
| Pedro Alvaro Amorrortu | Chief Operating Officer | 23. Januar 2019 A | 162.746 | 0 | 0 | $0 |
| Gabriel Brooks | Chief Medical Officer | 29. Januar 2026 A | 89.466 | 0 | 3 | $-280.978 |
| Paul Herzich | Chief Technology Officer | 29. Januar 2026 A | 72.638 | 0 | 4 | $-274.125 |
| Jessie Hanrahan | Chief Regulatory Officer | 29. Januar 2026 A | 74.318 | 0 | 4 | $-297.374 |
| Jennifer Marlowe | CSO | 13. Februar 2024 A | 6.998 | 0 | 0 | $0 |
| Carl Ashley Morris | Chief Scientific Officer | 27. Januar 2023 M | 19.760 | 0 | 0 | $0 |
| Erin Powers Brennan | Chief Legal Officer, Secretary | 2. Mai 2022 A | · | 0 | 0 | $0 |
| Lynette Herscha | Chief Legal Officer | 27. Juli 2020 M | 160.859 | 0 | 0 | $0 |
| Jorge Armando Quiroz | Chief Medical Officer | 23. Januar 2019 A | 228.092 | 0 | 0 | $0 |
| Ian F Smith | Direktor | 2. Juli 2026 M | 138.145 | 0 | 0 | $0 |
| Clare Kahn | Direktor | 10. Juni 2026 A | 2.960 | 0 | 0 | $0 |
| Georgia Keresty | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Lynne Marie Sullivan | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Ilan Ganot | Direktor | 10. Juni 2026 A | 27.474 | 0 | 5 | $-82.352 |
| Adam Leo Stone | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Martin I Freed | Direktor | 10. Juni 2026 A | 53.763 | 0 | 0 | $0 |
| Sukumar Nagendran | Direktor | 10. Juni 2026 A | 34.258 | 0 | 0 | $0 |
| Adam Koppel | Direktor | 11. Januar 2024 A | 4.034.582 | 0 | 0 | $0 |
| Robert Luther Huffines | Direktor | 13. Dezember 2022 A | · | 0 | 0 | $0 |
| Rajeev Shah | Direktor | 16. Juni 2021 A | 8.709.882 | 0 | 0 | $0 |
| Matthew Bennett Arnold | Direktor | 10. Dezember 2020 A | 3.933.429 | 0 | 0 | $0 |
| Juan Andrey Zarur | Direktor | 2. Januar 2020 A | 10.189 | 0 | 0 | $0 |
| Boxer Capital, LLC | 10%-Eigentümer | 28. März 2019 S | 3.473.272 | 0 | 0 | $0 |
| Gilad David Hayeem | 10%-Eigentümer | 22. August 2018 G | 1.948.991 | 0 | 0 | $0 |
| Joel Solomon Zev Schneider | · | 14. März 2022 S | 236.270 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 29 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,76% | 43.531 NS | 31. Juli 2026 | N-PORT |
| IBRN · iShares Trust | 0,74% | 6.132 SH | 11. September 2026 | Täglich |
| IWC · iShares Trust | 0,17% | 267.842 SH | 11. September 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,14% | 87.747 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,05% | 598.147 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 7.592 SH | 1. Oktober 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,04% | 1.199 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,03% | 50.645 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 35.267 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 102.425 SH | 1. Oktober 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 2.015.412 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 359.257 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 37.599 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 452.695 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 41.246 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,02% | 293.621 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 773.750 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 163.029 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 2.475 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 7.422 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 10.716 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 19.273 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 77.462 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 111.903 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 24.592 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 20.397 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.148.576 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.707 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 371.548 SH | 11. September 2026 | Täglich |
SLDB Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 19 Analysten
KAUF
Median-Ziel
$18.00
+162,8%
8 42,1%
Starker Kauf
10 52,6%
Kauf
1 5,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
13 Analysten · 2026-09-28Mittelwert-Ziel $18.62 +171,8%
← Unter allen Zielen
Aktueller Preis $6.85
Tief$11.00
Mittelwert$18.62
Hoch$26.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| ACHV | · | -4.0 | · | · | · | · |
| FTH | · | · | · | · | · | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| OLMA | $2.03B | -13.4 | · | · | -39.4% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026